Kymera Therapeutics, Inc. · NASDAQ:KYMR

Jacobs Bruce N. exercised options for 12,653 Kymera Therapeutics, Inc. shares (Form 4)

Traded Jun 2, 2026 · Filed Jun 3, 2026

On Jun 2, 2026, Jacobs Bruce N. (Chief Financial Officer) exercised options for 12,653 Kymera Therapeutics, Inc. shares at US$2.08 for US$26,318, leaving 260,241 shares. Filed Jun 3, 2026 (Form 4).

Options exercised
12,653 shares
Price
US$2.08
Value
US$26,318
Holding after
260,241 shares
Trading plan
No
Role
Chief Financial Officer

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Jun 2, 2026Common StockOption exercise12,653US$2.08260,241Direct

Source

View original at SEC

Related